Disease severity and associated family impact in childhood atopic dermatitis

被引:45
作者
Balkrishnan, R [1 ]
Housman, TS [1 ]
Carroll, C [1 ]
Feldman, SR [1 ]
Fleischer, AB [1 ]
机构
[1] Wake Forest Univ, Bowman Gray Sch Med, Dept Dermatol, Winston Salem, NC 27157 USA
关键词
D O I
10.1136/adc.88.5.423
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Aim: To examine the association between childhood atopic dermatitis (AD) severity and family impact at baseline and after an intervention by a physician specialist, using validated measures of both severity and family impact. Methods: Cross sectional self administered survey of parent-caregivers of 49 randomly selected children with AD; 35 parents were available for follow up. Family impact was measured using a modified AD Family Impact Scale completed by the parent-caregiver. The child's disease severity was measured using both the investigator's assessment via the Eczema Area and Severity Index (EASI) and the caregiver's assessment via the recently validated Self Assessment Eczema Area and Severity Index (SA-EASI). Results: The parent-caregiver's assessment of severity of the child was the most significant correlate of the family impact of the child's AD (p = 0.65 at baseline and p = 0.38 at follow up). In multivariate regression models, the parent-caregiver's estimate of severity remained the single strongest predictor of family impact before and after receipt of dermatologist care, as well as the difference in impact between pre and post-dermatologist care. Conclusions: There is evidence to support the ability of parent-caregivers of children with AD to accurately determine severity of their child's AD; perceived severity is the driver of the family impact of this condition. Treatment of a child by a physician specialist is associated with reductions in both perceived severity, as well as family impact of this condition.
引用
收藏
页码:423 / 427
页数:5
相关论文
共 19 条
[1]  
[Anonymous], STAT POWER ANAL BEHA
[2]   The family impact of atopic dermatitis in children: The role of the parent caregiver [J].
Balkrishnan, R ;
Housman, TS ;
Grummer, S ;
Rapp, SR ;
Clarke, J ;
Feldman, SR ;
Fleischer, AB .
PEDIATRIC DERMATOLOGY, 2003, 20 (01) :5-10
[3]  
Balkrishnan Rajesh, 2002, J Pediatr Health Care, V16, P73, DOI 10.1016/S0891-5245(02)50968-8
[4]   A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children [J].
Boguniewicz, M ;
Fiedler, VC ;
Raimer, S ;
Lawrence, ID ;
Leung, DYM ;
Hanifin, JM .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 102 (04) :637-644
[5]   PSYCHOSOCIAL ADJUSTMENT IN PRESCHOOL-CHILDREN WITH ATOPIC ECZEMA [J].
DAUD, LR ;
GARRALDA, ME ;
DAVID, TJ .
ARCHIVES OF DISEASE IN CHILDHOOD, 1993, 69 (06) :670-676
[6]   The epidemiology and experience of atopic eczema during childhood: a discussion paper on the implications of current knowledge for health care, public health policy and research [J].
Fennessy, M ;
Coupland, S ;
Popay, J ;
Naysmith, K .
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2000, 54 (08) :581-589
[7]  
Greene WilliamH., 1998, ECONOMETRIC ANAL, Vfourth
[8]   The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis [J].
Hanifin, JM ;
Thurston, M ;
Omoto, M ;
Cherill, R ;
Tofte, SJ ;
Graeber, M .
EXPERIMENTAL DERMATOLOGY, 2001, 10 (01) :11-18
[9]  
Helmbold P, 2000, ACTA DERM-VENEREOL, V80, P348
[10]   Use of the Self-Administered Eczema Area and Severity Index by parent caregivers: results of a validation study [J].
Housman, TS ;
Patel, MJ ;
Camacho, F ;
Feldman, SR ;
Fleischer, AB ;
Balkrishnan, R .
BRITISH JOURNAL OF DERMATOLOGY, 2002, 147 (06) :1192-1198